Creating an AI-ready data foundation for successful AI-enabled drug discovery
Over the past year, we have looked at drug discovery and development from several different...
Over the past year, we have looked at drug discovery and development from several different...
Simon joins the BioStrand team fresh out of university, where he graduated with a Bachelor’s in...
The year 2022 in computational biology was largely marked by two main advancements:
It’s been another momentous year for the global life sciences industry. Ever since the pandemic...
I recently had the privilege of representing the BioStrand Team at BioTechX, Europe’s largest...
The key challenge to understanding complex biological systems is that they cannot be simply decoded...
Carlo joined Lensai (IPA) as Head of Technology in 2022, bringing with him over two decades of...
The use of AI in drug discovery has been progressively expanding over the past decade. Over the...
A biomarker, or biological marker, broadly refers to a range of objectively, accurately, and...
Currently, chemotherapy, using cytotoxic small molecules to kill cancer cells, is the predominant...
In our Employee Spotlight series, we focus on key individuals from our growing network of thought...